Safety and Efficacy of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler Compared with Fluticasone Propionate/Salmeterol Diskus in Patients with Chronic...

per Koser, Andras, Westerman, Jan, Sharma, Sanjay, Emmett, Amanda, Crater, Glenn D
Publicat 2010

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk

per Covelli, Henry, Pek, Bonavuth, Schenkenberger, Isabelle, Scott-Wilson, Catherine, Emmett, Amanda, Crim, Courtney
Publicat a Int J Chron Obstruct Pulmon Dis (2015)

Disease severity and symptoms among patients receiving monotherapy for COPD

per Dransfield, Mark T, Bailey, William, Crater, Glenn, Emmett, Amanda, O'Dell, Dianne M, Yawn, Barbara
Publicat a Prim Care Respir J (2011)

A Patient-Centered Walking Program for COPD

per Bender, Bruce G., Depew, Ann, Emmett, Amanda, Goelz, Kelly, Make, Barry, Sharma, Sanjay, Underwood, Jennifer, Stempel, David
Publicat a Chronic Obstr Pulm Dis (2016)

A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

per Crim, Courtney, Gotfried, Mark, Spangenthal, Selwyn, Watkins, Michael, Emmett, Amanda, Crawford, Catriona, Baidoo, Charlotte, Castro-Santamaria, Ramiro
Publicat a BMC Pulm Med (2020)

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

per Ohar, Jill A, Crater, Glenn D, Emmett, Amanda, Ferro, Thomas J, Morris, Andrea N, Raphiou, Ibrahim, Sriram, Peruvemba S, Dransfield, Mark T
Publicat 2014

Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts

per Forns, Xavier, Feld, Jordan J., Dylla, Douglas E., Pol, Stanislas, Chayama, Kazuaki, Hou, Jinlin, Heo, Jeong, Lampertico, Pietro, Brown, Ashley, Bondin, Mark, Tatsch, Fernando, Burroughs, Margaret, Marcinak, John, Zhang, Zhenzhen, Emmett, Amanda, Gordon, Stuart C., Jacobson, Ira M.
Publicat a Adv Ther (2021)